In a significant development, pharmaceutical company AstraZeneca on Tuesday (September 8) said that it “voluntarily paused” the phase 3 clinical human trials of its vaccine candidate ‘Covishield’ after one of the volunteers got ill. It is to be noted that AstraZeneca is developing this vaccine in collaboration with University of Oxford.
from Zee News :World https://ift.tt/3hd1cvJ
via
from Zee News :World https://ift.tt/3hd1cvJ
via